Adeno-associated virus type 2 (AAV-2) is a human parvovirus dependent on coinfection with a helper virus, such as adenovirus or herpesvirus, for efficient reproduction (for reviews, see references 2, 3, and 28). The 4.7-kb single-stranded DNA (ssDNA) genome is encapsidated in an icosahedral virion 20 to 24 nm in diameter. The genome consists of two open reading frames (ORFs) flanked by inverted terminal repeats (ITRs) of 145 nucleotides. The right ORF encodes the three capsid proteins VP1, VP2, and VP3, which are translated from alternative translation start sites and have molecular masses of 87, 72, and 62 kDa, respectively. The capsid proteins are present in the mature virion in a 1:1:10 ratio (4, 33) . Capsid assembly occurs in the nucleus and requires only the expression of the capsid proteins (34, 45) . In the absence of Rep proteins, capsids accumulate predominantly in the nuceoli (45) . Encapsidation of the ssDNA takes place in the nucleoplasm. Immunofluorescence data indicate that the capsid proteins and the nonstructural Rep proteins colocalize in certain areas of the nucleus (18, 45) and that the Rep proteins are able to influence the subnuclear capsid distribution (45) . Coimmunoprecipitation experiments have shown that Rep and capsid proteins can form complexes (31, 46) . These complexes are at least partially stabilized by covalent linkage of Rep78 to singlestranded AAV-2 DNA in the virion (32) , in analogy to findings for the autonomous parvovirus minute virus of mice (MVM) (8) .
The left ORF encodes the four nonstructural Rep proteins, with molecular masses of 78, 68, 52, and 40 kDa, respectively. The two large Rep proteins are required for AAV-2 DNA replication (14, 40) and influence AAV-2 gene expression (1, 17, 24, 30, 41, 42) . They have ATP-dependent helicase and endonuclease activities (19, 21) . The two small Rep proteins strongly stimulate ssDNA accumulation (6) , which may suggest a role in ssDNA encapsidation. In principle, Rep78 and Rep68 are sufficient for the production of infectious virions (15) ; however, coexpression of Rep52 and Rep40 increases the infectious titer by up to 1,000-fold. Recent experiments also revealed an ATP-dependent helicase activity associated with Rep52 (37) .
The two ITRs of the AAV genome serve as origins of AAV DNA replication and are necessary and sufficient for packaging (26, 35) . A specific packaging sequence within the ITR has so far not been identified. In vivo pulse-labeling experiments have shown that the number of empty particles decreases at the same rate as the number of DNA-containing mature virions increases over the course of a viral infection (29) . Interpretation of these data led to the hypothesis that ssDNA is packaged into preformed empty capsids. This model is supported by findings relating to autonomous parvoviruses for which capsids with attached DNA as potential packaging intermediates have been visualized by electron microscopy (27) . Recently, infectious AAV-2 has been produced in cell-free systems which might help to analyze the mechanism of DNA encapsidation in more detail (9, 47) .
Encapsidation of the DNA is a crucial step in the production of wild-type and recombinant AAV-2. In both cases, the num-ber of empty capsids exceeds the number of packaged infectious virions. The underlying mechanisms both of capsid assembly and DNA packaging are not yet understood. In particular, there is no explanation for the apparent specificity of the AAV-2 DNA packaging process. Here we describe complexes between Rep proteins and capsids as well as between different Rep proteins which provide a molecular basis for the specific association of AAV-2 DNA with preformed capsids prior to encapsidation. A model describing the formation of the initial encapsidation complexes is presented.
MATERIALS AND METHODS

Materials.
The polyclonal guinea pig Rep antisera ␣Rep-S, ␣Rep-M, and ␣Rep-A against the Rep proteins derived from spliced mRNAs (Rep68 and Rep40) and against all Rep proteins, respectively, and the monoclonal antibodies (MAbs) 303.9 (directed against the Rep proteins) and B1 (directed against the capsid proteins) have been described previously (42, 46) . A polyclonal guinea pig antiserum (␣Rep-US) specifically reacting with the Rep proteins derived from the nonspliced mRNAs (Rep78 and Rep52) was generated by immunization of guinea pigs with the peptide GKVPDACTACDLVNVDLDDCIFEQ according to conventional protocols (12) . The rabbit polyclonal antisera 48, 51, and 87, reacting with the VP proteins, were prepared after immunization by using the VP1 capsid protein which was expressed in a baculovirus system and then gel purified.
The expression vectors pRep, including Rep78, Rep68, Rep52, Rep40, M225, M274, M324, Stop482, Stop515, and RepK340H are identical to the corresponding pKEXRep constructs previously described (17) . The mutant Rep52⌬XS was generated via deletion of the XmnI-SalI region of Rep52. Through blunting of the SalI site and ligation to the blunt XmnI end, the original Rep reading frame was conserved. Constructs containing point mutations (E379K, E379Q, E391I, E391T, K404I, K404T, and P415H) in the Rep helicase domain have been previously described (25) and were kindly provided by N. Muzyczka. SalI-SwaI fragments were removed from these Rep/Cap expression constructs and inserted into a cytomegalovirus (CMV)-Rep52/40 expression construct (pRepM225). pDG⌬VP was prepared by homologous recombination. For this, a 1.1-kb ApaI fragment which comprises nucleotides 2946 to 4049 of the VP ORF was deleted from p⌬TR (42) , resulting in plasmid p⌬TR⌬VP. The 1.8-kb XbaI/HindIII fragment from p⌬TR⌬VP was then cotransformed with pDG (11) linearized with SwaI into Escherichia coli BJ5183 for homologous recombination (5) .
For quantitation of the sensitivity of MAbs 303.9 and B1, Rep68 and VP3 were expressed and purified as described earlier (16, 38) .
Cell culture, virus infection, and plasmid transfection. 293T cells were maintained in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% heat-inactivated fetal calf serum and 100 g/ml of penicillin and streptomycin at 37°C in 5% CO 2 . Cells were coinfected with AAV-2 and adenovirus type 5 (Ad5) at 80% confluency. The medium was removed, and the cells were then incubated with AAV-2 (multiplicity of infection [MOI] of 20) and Ad5 (MOI of 2) in a total volume of 500 l per 6-cm-diameter petri dish for 2 h. DMEM was added, and the cells were incubated at 37°C in 5% CO 2 for 72 h. Cells were transfected as described elsewhere (7) . 293T cells at approximately 60% confluency were transfected with 10 g of plasmid DNA per 6-cm petri dish.
Preparation of cell extracts. The cells were harvested at 72 h postinfection or posttransfection and washed with 5 ml of phosphate-buffered saline (PBS) and then with 1 ml of PBS per dish. Cells from a 6-cm dish were resuspended in a final volume of 0.5 ml or in 1 ml of buffer A (10 mM Tris-Cl, pH 7.5, 100 mM NaCl, 1 mM EDTA) or RIPA buffer (10 mM Tris-Cl, pH 7.5, 150 mM NaCl, 1 mM EDTA, 1% Nonidet P-40, 0.5% sodium deoxycholate, 0.1% sodium dodecyl sulfate [SDS]). To both buffers the complete proteinase inhibitor cocktail (Roche, Mannheim, Germany) was added as suggested by the manufacturer. The cell suspensions in buffer A were sonicated twice for 15 s. All extracts were cleared by centrifugation at an average of 17,600 ϫ g for 5 min (4°C).
Sucrose gradients. Nuclear extracts of 293T cells transfected with pDG from 10 10-cm petri dishes were prepared as previously described (46) . Samples of 0.5 ml were loaded onto 10-ml sucrose gradients (5 to 30% sucrose in TNEM buffer [10 mM Tris-Cl, pH 7.5, 100 mM NaCl, 1 mM EDTA, 2 mM MgCl 2 , 5 mM ␤-mercaptoethanol]) and centrifuged for 2 h at 160,000 ϫ g at 4°C in a swing-out rotor. Fractions of 1 ml were collected from the bottoms of the tubes. Rep and VP concentrations were controlled by precipitation in trichloroacetic acid (final concentration of 20%) of 200 l of the fractions, followed by SDS-polyacrylamide gel electrophoresis (PAGE) and Western blot analysis. The remaining 800 l of the fractions was used for immunoprecipitation experiments.
Western blot analysis. Protein samples were electrophoresed on 15% polyacrylamide gels in the presence of SDS (39) and transferred to nitrocellulose membranes using semidry blotting equipment. The Rep and capsid proteins were detected with MAbs and peroxidase-coupled secondary antibodies using the enhanced chemoluminescence (ECL) detection kit (Amersham, Braunschweig, Germany) according to standard methods (12) .
Immunoprecipitation experiments. Three hundred to 500 l of cell extract or 800 l of sucrose gradient fractions was incubated overnight at 4°C with either 3 l of polyclonal guinea pig antiserum or polyclonal rabbit antiserum. After this incubation, the samples were cleared of nonspecific protein precipitates by centrifugation at 17,600 ϫ g for 5 min. The immunocomplexes were precipitated via the addition of 30 l of protein A-Sepharose (Amersham-Pharmacia, Freiburg, Germany) (10% [wt/vol] in NETN [20 mM Tris-Cl, pH 7.5, 100 mM NaCl, 1 mM EDTA, 0.5% Nonidet P-40]). After overnight incubation at 4°C, the immunocomplex-protein A-Sepharose beads were washed three times with 1 ml of NETN buffer in which guinea pig antisera had been used. Immunoprecipitations carried out using rabbit antisera in RIPA buffer or buffer A were washed three times with 1 ml of the respective lysis buffer instead of NETN. The samples were boiled in protein loading buffer and analyzed by SDS-PAGE and Western blotting.
Two-hybrid vectors and interaction assay. The Rep two-hybrid constructs were cloned as follows. Plasmids pGBT9 and pGAD424 (Clontech Laboratories, Inc., Palo Alto, Calif.) encoding the GAL4 DNA-binding and the GAL4 transactivation domain, respectively, were cut with SalI and PstI and ligated to a SalI/PstI fragment from HIV-LTR-OVEC (16) containing the EcoRV site derived from pBluescript SK2 adjacent to the PstI site. The resulting plasmids were digested with SalI and partially with EcoRV to excise only the HIV-LTR-derived inserts. The vector fragments were ligated to Rep78-and Rep52-encoding XhoI/ SmaI fragments from pRep78 and pRep52, respectively, to obtain pGBT9-Rep78, pGBT-Rep52, pGAD424-Rep78, and pGAD424-Rep52. To generate the Rep68-and Rep40-encoding two-hybrid constructs, the NotI/XbaI-Rep78 fragments of pGBT9-Rep78 and pGAD424-Rep78, respectively, were replaced by the corresponding fragments from pRep68 and pRep40. The vector for the expression of the AAV-2 VP proteins in fusion with the yeast GAL4 activation domain (pGAD-VP) was generated by inserting the DraI/SnaBI fragment of pTAV2-0 into the blunted BamHI site of pGAD424. The corresponding pGBT-VP construct containing the AAV-2 cap gene fused to the gene for the yeast GAL4-binding domain was prepared by ligating the VP-containing EcoRI/ SalI fragment of pGAD-VP into pGBT9 that had been digested with EcoRI and SalI.
The constructs were transformed according to a basic lithium acetate protocol (10) in every possible pairwise combination into Saccharomyces cerevisiae PJ69-4 (22), which contains three reporter genes, ADE2, HIS3, and lacZ, under the control of three independent promoters, Gal2, Gal1, and Gal7. The resulting 36 double transformants were selected on synthetic complete medium lacking leucine and tryptophan.
For the in vivo assays, fresh transformants were streaked onto tryptophan-and leucine-deficient medium lacking adenine or histidine or supplemented with a final concentration of 100 mM sodium phosphate (pH 7.0) and 40 g of X-Gal (5-bromo-4-chloro-3-indolyl-␤-D-galactopyranoside) per ml, respectively, and incubated for 72 h at 30°C. Cotransformants displaying a positive reaction on at least one of the selective media were subjected to a liquid culture assay by quantitative colorimetric measurement of ␤-galactosidase activity using chlorophenol red ␤-D-galactopyranoside (CPRG) (36) . The liquid culture assay was performed at least twice with three independent cotransformants and triple measurements.
RESULTS
Complex formation between Rep and VP proteins in the absence of packageable DNA. In the course of a productive AAV-2 infection, complexes between Rep and capsid proteins (VP proteins) can be demonstrated by coimmunoprecipitation with antibodies against the Rep proteins (31, 46). These complexes have been interpreted as being the result of ssDNA packaging in which Rep is covalently linked to the viral DNA and thereby indirectly associated with the capsid (31, 32) . To determine whether the association of Rep proteins with capsid proteins or capsids requires AAV-2 DNA, Rep-VP complex formation was studied following transfection of Rep and VP protein expression constructs in the presence and absence of replicatable and packageable DNA. 293T cells were cotransfected either with the AAV-2 vector plasmid pUF2 ( Fig. 1 ) (48) and the helper plasmid pDG ( Fig. 1 ) (11), which provides AAV-2 and all adenovirus helper functions, or with pBluescript SKϩ (pBS), a plasmid which can neither be replicated nor packaged into AAV-2 capsids, and the pDG helper plasmid. As a positive control, 293T cells were infected with AAV-2 (MOI, 20) and Ad5 (MOI, 2) or transfected with pTAV2-0 ( Fig. 1) , an infectious AAV-2 clone, and infected with Ad5 (MOI, 2). The Rep proteins were immunoprecipitated from extracts of cells harvested 72 h postinfection or posttransfection with polyclonal guinea pig antisera recogniz-ing all four Rep proteins (␣Rep-A or ␣Rep-M). Coprecipitated capsid proteins were detected by SDS-PAGE and Western blot analysis by using the monoclonal antibody B1 (45) . It is evident from Fig. 2a that capsid proteins can be coprecipitated with the Rep proteins to the same extent following transfection of the pTAV2-0 infectious clone as after infection. In addition, coimmunoprecipitation of VP proteins occurred not only in the presence of replication-and packaging-competent DNA (pUF2) but also in the presence of replication-and packaging-deficient DNA (pBS) (Fig. 2b) . Control precipitations with an unrelated guinea pig antiserum showed no precipitation of capsid proteins. To further validate these results, coimmunoprecipitations using two additional polyclonal antisera were performed from extracts of cells transfected with pDG alone. The specificities of the various guinea pig antisera were demonstrated by Western blot analysis (Fig. 2c) . Whereas the ␣Rep-S antiserum reacts only with Rep40 and Rep68 (see also reference 42), ␣Rep-US specifically detects Rep78 and Rep52 in Western blot analysis. Both ␣Rep-S and ␣Rep-US coprecipitated the capsid proteins, indicating that Rep proteins derived from spliced and unspliced mRNA form complexes with the VP proteins (Fig. 2d ). In addition, this result confirms that packageable DNA is not required for Rep-VP complex formation.
Mapping of the VP interaction domain of the Rep proteins. The ability of individual Rep proteins and Rep protein mutants to form complexes with VP proteins was tested by cotransfecting increasing amounts of the pCMV-VP expression construct (2, 4, or 8 g) ( Larger amounts of VP proteins were coprecipitated using the small Rep proteins than with the large Rep proteins. C-and N-terminal deletions as well as point mutations in the ATPbinding site of the Rep proteins and in proline 415 further reduced the interaction with the capsid proteins. An internal deletion between amino acids 322 and 370 (Rep52⌬XS) showed no detectable VP coprecipitation ( Fig. 3b and c) . This mutant turned out to be less soluble within the cell and therefore could only be tested at a reduced expression level. We concluded from these results that each of the Rep proteins is able to form complexes with the capsid proteins and that the most important interaction site(s) is contained within the domain spanning amino acids 322 to 482.
Characterization of Rep-VP complexes. Since Rep-VP complex formation was not restricted to a subset of the four Rep proteins, the Rep content of the Rep-VP complexes was analyzed. Extracts of 293T cells that had been infected with AAV-2 (MOI, 20) and Ad5 (MOI, 2) were immunoprecipitated in the presence of RIPA buffer by using either a polyclonal VP antiserum (␣VP#87) or the preimmune serum. The precipitates thus obtained were analyzed using a MAb (303.9) that reacts with all four Rep proteins. It becomes obvious from Fig. 4a that Rep52 was overrepresented in the precipitate, whereas Rep78 and Rep68 were present in lower amounts, although comparison with total Rep protein concentration present in the cell extract (Fig. 4a, extract lanes) shows that Rep78 and Rep68 were abundantly expressed. Rep40 was generally not detected in the immunoprecipitates except in low amounts in experiments in which Rep40 was more highly expressed. The same result was obtained from immunoprecipitations using two other anti-VP polyclonal rabbit antisera (#48 and #51) or after transfection of 293T cells with pTAV2-0 and overinfection with Ad5 (MOI, 5) (data not shown). No Rep proteins were detected following immunoprecipitation with the preimmune serum (control lanes). Immunoprecipitations shown so far were performed using RIPA cell extracts that contain considerable amounts of detergents. In order to analyze the composition of Rep-VP complexes under less stringent conditions, cell extracts prepared using detergent-free buffer A were used for immunoprecipitation with the VP antiserum (␣VP#87). Figure 4b shows that under these conditions, considerably more Rep78 was recovered in the immunoprecipitate (lane ␣VP) than in the precipitation in RIPA buffer compared to the expression level of the Rep proteins in the cell extract (extract lane). However, such precipitations always showed a higher background with the preimmune serum (control lane).
The Rep content of Rep-VP complexes in the absence of (Fig. 4c, ␣VP) . Rep52 was present in higher amounts than Rep78, although the relative amount of Rep78 in the cell extract was almost equal to that of Rep52 (compare extract and ␣VP lanes). Rep68 and Rep40 were neither detected in the extract nor in the immunoprecipitate. In the immunoprecipitate obtained from 293T cells transfected with pDG⌬VP ( Fig. 1 ) in which the cap gene was deleted, no Rep proteins could be detected (Fig. 4c) , demonstrating the specificity of the immunoprecipitates. In addition, control precipitations with the preimmune serum did not coprecipitate significant amounts of Rep proteins. The broad faint band at the position of Rep52 represents the immunoglobulin G (IgG) heavy chain fraction of the antiserum weakly detected by the anti-mouse secondary antibody used in the Western blot analysis.
The composition of the Rep-VP complexes formed in the absence of packageable AAV-2 DNA was also analyzed by cosedimentation of Rep proteins with capsids at 60S. In these experiments, nuclear extracts of cells transfected with pDG or pDG⌬VP were fractionated by sucrose gradient centrifugation and subjected to Western blotting using VP antibodies (B1) or Rep antibodies (303.9). In some experiments, the Rep and VP proteins were concentrated by immunoprecipitation with antiRep antibodies prior to Western blot analysis (Fig. 4d) ; however, similar results were obtained without this concentration step (data not shown). It is evident that Rep78 and Rep52 show a peak in the capsid-containing fractions around 60S which does not appear in the absence of capsids (Fig. 4d, lanes  pDG⌬VP) . This result was obtained in a detergent-free buffer system. It also shows that the DNA-free complexes contain predominantly Rep78 and Rep52 (at slightly higher levels). The repeatedly observed protein band that migrates slightly below Rep40 may represent a modified form of Rep40 or a degradation product of one of the four Rep proteins. The quantitation of the Rep and VP proteins in the 60S fractions from two representative sucrose gradients suggests that the Rep proteins are present in the 60S complexes in amounts comparable to or slightly higher than VP2 (Table 1) . Association of Rep proteins with free and assembled capsid proteins. In order to determine whether the Rep-VP interaction occurs prior or subsequent to capsid assembly, the interactions of Rep proteins with nonassembled capsid proteins were analyzed. Nuclear extracts of pDG-transfected 293T cells were subjected to sucrose gradient centrifugation, and the resulting fractions were used in coimmunoprecipitation experiments. Using the ␣Rep-A antiserum, capsid proteins were predominantly coprecipitated from fractions containing the fully assembled capsids, around 60S (Fig. 5a) . However, some capsid proteins were also specifically coprecipitated in fractions corresponding to S values of less than 20S, suggesting that Rep proteins are not only associated with the assembled capsids but also with nonassembled VP proteins. To confirm the association of Rep proteins with free capsid proteins, coimmunoprecipitation experiments were performed via cotransfection of 293T with the various Rep expression constructs (pRep40, pRep52, pRep68, or pRep78) and constructs from which the individual capsid proteins VP1, VP2, or VP3 (Fig. 1,  pKEX-VP1 , pKEX-VP2, and pKEX-VP3) are expressed (34), but they show very poor or, in the case of VP3, no capsid assembly (38) . To monitor Rep association with capsids, the three capsid proteins were coexpressed from plasmid pCMV-VP (45) . Using the ␣Rep-A antiserum, only small amounts of the separately expressed VP3 or VP2 and no VP1 could be detected, whereas the assembled capsids (lane VP) in the control experiment were abundantly recovered ( Fig. 5c and d ; only the experiment with pRep40 is shown; similar results were obtained for the other Rep proteins). These results demonstrate that VP3 and probably also VP2 are able to interact with the Rep proteins also in their nonassembled states. The specificity of these precipitations is shown by the two controls (Fig. 5c , lane pKEX/VP, and 5d). The relatively weak VP signals obtained following coprecipitation of individual VP proteins with the Rep proteins can be explained by the small amount of VP molecules present in these complexes, compared to complexes involving capsids. Finally, data from two-hybrid interaction assays also suggest that Rep78 and Rep52 can interact with nonassembled VP proteins (see Fig. 8D and E). Such interactions were not observed in this assay for the other Rep proteins.
From the data so far obtained, Rep-capsid complexes could either be formed by the association of Rep proteins with assembled capsids or with VP proteins during the assembly process. To distinguish between the two mechanisms, we compared Rep-capsid complexes obtained by coexpression of Rep and capsid proteins with complexes obtained upon separate expression and coincubation of the extracts in vitro. Very little capsid assembly occurs in vitro (38) , so that any resulting interactions of Rep proteins with capsids or VP proteins can be said to be assembly independent. Whereas coexpression of Rep40 with the VP proteins led to the formation of a stable complex, no VP proteins were coprecipitated with Rep40 when the Rep and VP proteins were separately expressed and then mixed in vitro (Fig. 6) . Similar results were obtained using Rep52 (data not shown). This result also emphasizes that the abundance of the capsid proteins in the cell extract does not lead to a nonspecific coprecipitation with the Rep proteins.
Taken together, these data suggest that complex formation involving the VP and Rep proteins occurs during capsid assembly and results in the formation of stable Rep-capsid complexes that cannot be formed by mixing cellular extracts in vitro.
Rep-Rep complex formation. Since all Rep proteins are able to form complexes with VP proteins, we were interested in determining whether Rep-Rep protein interactions could contribute to a capsid-associated Rep protein complex possibly involved in AAV-2 DNA packaging. Rep-Rep protein interactions were investigated by coimmunoprecipitation and twohybrid analyses.
The individual Rep proteins were either expressed sepa- (10 10-cm petri dishes; 15 g of pDG each) were subjected to immunoprecipitation with the ␣Rep-A or control polyclonal antisera in RIPA buffer as described in Materials and Methods. The positions of 60S and 20S were determined by using empty AAV-2 capsids (60S) and ␣-macroglobulin (20S) in parallel gradients. (c and d) 293T cells were cotransfected with the expression constructs pRep40 (4 g/6-cm petri dish) and pCMV-VP (VP), pKEX-VP3 (VP3), pKEX-VP2 (VP2), and pKEX-VP1 (VP1) (2 or 6 g/6-cm petri dish) or with the empty vector pKEX (4 g/6-cm petri dish) and pCMV-VP (VP) (6 g/6-cm petri dish). Whole cell extracts were immunoprecipitated with the ␣Rep-A and control antisera in RIPA buffer as described in Materials and Methods. VP proteins were detected by Western blotting using MAb B1 and ECL. M, marker extract derived from HeLa cells coinfected with AAV-2 and Ad5. IgG, position of guinea pig IgG immunoprecipitated with protein A-Sepharose cross-reacting with the peroxidase-coupled anti-mouse secondary antibody. rately or in combination via cotransfection and immunoprecipitated using ␣Rep-S or ␣Rep-US polyclonal antisera. Extracts were prepared in buffer A, because the detergents present in RIPA buffer destabilize Rep-Rep interactions. The immunoprecipitated proteins were visualized by Western blot analysis. Small amounts of Rep52 and Rep78 could be coimmunoprecipitated with Rep40 (Fig. 7) . With Rep68, however, Rep78 was coprecipitated in a 1:1 ratio. An interaction between Rep68 and Rep52 was difficult to detect using ␣Rep-S, since a polypeptide of about the same molecular weight as Rep52, which also reacted with the 303.9 antibody, was precipitated after expression of Rep68 alone (Fig. 7, ␣Rep-S, lane   68 ). This protein most likely represents a degradation product of Rep68 that was still recognized by the ␣Rep-S serum. Immunoprecipitation using the ␣Rep-US antiserum, however, showed a clear coprecipitation of Rep68 with Rep52 as well as with Rep78, confirming and specifying a previously observed interaction of Rep52 with one of the large Rep proteins (30) . In contrast to the experiment with ␣Rep-S, the weak interactions of Rep40 with Rep52 and Rep78 could not be detected.
In the two-hybrid system, the Rep as well as the VP proteins were fused to the GAL4 activation (pGAD424) or binding (pGBT9) domains, respectively and cotransformed into the yeast strain PJ69-4 in every possible pairwise combination. The cotransformants were analyzed for the expression of three reporter genes under the control of the GAL4 activatable promoters Gal1, Gal2, and Gal7, respectively. Cotransformants able to activate the least stringent promoter (Gal7) were subjected to a quantitative ␤-galactosidase liquid culture assay. The ␤-galactosidase activities are indicated as Miller units (Fig. 8 ). Rep52 and Rep78 showed a background activation of all three promoters when fused to the GAL4 DNA-binding domain. Based on these assays, clear interactions could be demonstrated for Rep52 and Rep68 as well as for Rep68 and Rep78 fused to either of the GAL4 domains ( Fig. 8B and C) , thus supporting the results from the coimmunoprecipitation experiments. Rep52 and Rep40 showed a slight activation of the Gal7 promoter only when Rep40 was fused to the GAL4 activation domain (Fig. 8A) .
Taken together, these data demonstrate binding of Rep52 to Rep68 as well as Rep68 to Rep78 and also indicate that Rep40 can weakly bind both Rep52 and Rep78.
DISCUSSION
In this report we have described the protein-protein interactions of AAV-2-encoded polypeptides which result in complexes between Rep proteins and AAV-2 capsids. The same type of complex was formed regardless of whether packageable DNA was present, suggesting that it is not formed as the result of DNA packaging but rather constitutes an intermediate required for encapsidation. Several reports have previously described complexes of Rep proteins with AAV-2 capsids (23, 31, 32, 46) . However, they have been primarily interpreted based on the MVMp paradigm described by Cotmore and Tattersall (8) , as a covalent linkage of Rep78 or Rep68 to the 5Ј terminus of the genome formed during the terminal resolution reaction and preserved at the outside of the capsid after DNA packaging has been completed (31, 32) . A functional role for this type of complex has been discussed and linked to the nuclear uptake of parvovirus genomes during an infection or to the release of assembled virus from the cell (8, 31, 32) . Our interpretation suggests a role for Rep-VP complexes in the DNA packaging process, in particular at the initiation step during which the viral DNA must interact with the parvovirus capsid. A role in DNA packaging has also been favored by Cotmore and Tattersall (8) ; however, such a role would involve a DNA-independent protein-protein interaction between structural and nonstructural proteins, which the authors did not observe. Here, we have presented several lines of evidence demonstrating that such protein-protein interactions do indeed occur and that they result in capsids displaying Rep proteins on the outside of the viral shell. We have demonstrated this by coimmunoprecipitating capsids with four different anti-Rep antisera. Similarly, Rep proteins could be coprecipitated using three different anti-VP antisera but only when capsid proteins were coexpressed. We have also isolated Rep proteins by immunoaffinity chro- matography on a matrix bound by MAb A20, which recognizes assembled capsids (data not shown). In addition, the small Rep proteins, which do not show sequence-specific DNA binding (21) , can form complexes with VP, further suggesting that DNA is not involved in the initial complex formation. Analysis of Rep mutants showed that sequences near or within the ATP-binding domain are required for this interaction. Several Rep mutants showed strongly reduced or no interaction with capsids, emphasizing the specificity of the Rep-capsid associations. Finally, we could also detect a weak interaction of Rep78 and Rep52 with VP proteins by using the yeast two-hybrid system. A DNase-resistant complex of Rep proteins with recombinant and wild-type AAV-2 virions has also been observed by Kube et al. (23) , who suggested a relationship between the AAV-2-mediated influence on cell proliferation and the capsid-associated Rep proteins. The authors observed that the association of Rep proteins with the capsid surface is sensitive to repeated CsCl centrifugation, i.e., to high salt concentrations, which is in line with our own experience (data not shown). Additionally, an indirect piece of evidence supporting a DNA-independent interaction of Rep proteins with AAV-2 capsids is suggested by the strong influence that the Rep proteins have on the intranuclear localization of assembled empty capsids in HeLa cells (45) .
At this stage the mechanism by which protein-protein interactions can result in stable Rep-virion complexes is still unclear. Rep-VP interactions can occur prior to assembly of the capsid proteins into capsids. This is demonstrated by coimmunoprecipitation of VP proteins with anti-Rep antibodies from sucrose gradient fractions sedimenting below 20S, by coimmunoprecipitation of individually expressed capsid proteins which have a strongly reduced capsid forming capacity (38) , and by the two-hybrid system in which the capsid proteins are fused to protein domains and are therefore prevented from forming capsids. That this interaction with nonassembled VP proteins plays an important role in Rep-capsid complex formation is demonstrated by the fact that coexpression of Rep and VP proteins leads to a much more efficient complex formation than the mere association of Rep proteins with capsids in vitro. Complex formation in vitro may be less efficient for several reasons. The actual protein concentrations in the nucleus and the availability of chaperones would certainly be different during coexpression in vivo compared to coincubation in vitro, although the amounts of Rep and VP proteins in the extracts were the same. Nonetheless, the strikingly higher stability of complexes formed after coexpression, compared to that after coincubation, strongly suggests that protein-protein interactions during the assembly process are important for the formation of this type of Rep-capsid complex.
The composition of the Rep-capsid complexes, as determined by immunoprecipitation with different VP antibodies in the presence and absence of AAV-2 DNA, suggests an abundance of Rep52, slightly less Rep78, and a small amount of Rep68 associated with the capsid. In some experiments, we could also detect traces of Rep40. Since all Rep proteins are able to form such complexes when individually expressed with capsid proteins, one would expect that they are represented in the capsids according to their expression levels. Rep78 is normally expressed at equal or higher levels than Rep52 in coinfection experiments, yet the capsids precipitated in RIPA buffer always showed a higher content of Rep52 than of Rep78. That these ratios are not immunoprecipitation artefacts is supported by the quantitation of Rep and VP proteins in sucrose gradient fractions without any precipitation ( Table 1) . The determined ratios suggest a Rep78/VP2 ratio of about 1 and a slightly higher ratio of 2 to 4 for Rep52/VP2. However, an exact determination of the Rep/VP stoichiometry in these complexes would require a purification of the complexes. Precipitations performed in buffer A (without detergents) gave much higher recoveries of Rep78, suggesting a difference in the binding stabilities of Rep78 and Rep52 to the capsid. Since Rep-Rep interactions are unstable in RIPA buffer, the additional amounts of Rep78 (and Rep68) recovered by immunoprecipitation in buffer A could thus result from Rep-Rep interactions in addition to the detergent-stable complexes of Rep52, Rep78, and Rep68 with the capsid. The low levels of Rep40 in the Rep-capsid complexes is difficult to interpret, especially as capsids were very efficiently coprecipitated with Rep antisera when Rep40 was overexpressed together with the VP proteins. In infection experiments and after transfection of pDG, however, expression levels of Rep40 were variable, but altogether low, making it difficult to judge whether the low recovery in these experiments was due to the low protein concentration or rather to a lower stability of Rep40 in the complex. In several cosedimentation experiments, a polypeptide migrating slightly faster than Rep40 was observed at 60S. It remains to be determined whether this protein represents a modified form of Rep40 or a degradation product of one of the Rep proteins.
A problem that all viruses must solve is how to specifically package their genome. Current concepts for the solution of this problem postulate a specific interaction of a part of the genome, i.e., the packaging sequence, with components of the packaging apparatus and capsid. For the autonomous parvoviruses, a specific interaction of the 3Ј hairpin structure of MVM with the capsid (43) and an interaction of a 3Ј-terminal fragment of the Aleutian mink disease virus with VP1 (44) have been demonstrated. In contrast, a direct interaction of AAV-2 ITRs, which are necessary and sufficient for AAV-2 genome encapsidation, with free capsid proteins or capsids produced in the absence of Rep proteins could not be demonstrated. Alternatively, the required specific association of AAV-2 DNA with the capsids could be achieved through Rep78 or Rep68 binding to the AAV-2 ITRs (20), followed by interaction with the capsid. We can imagine two mechanisms by which this could be accomplished (Fig. 9) . The large Rep proteins bound to the AAV-2 DNA could (i) become directly incorporated into the capsid during capsid assembly or (ii) associate with capsids via interactions with the small and large Rep proteins already incorporated into the capsids. The fact that AAV-2 DNA packaging can be reconstituted in cell-free extracts (9, 47) tends to favor the second mechanism, because capsid assembly in such cell-free systems is inefficient (38) . A preencapsidation complex, as postulated by this model, could also explain how the packaging of AAV-2 DNA genomes engaged in DNA replication or mRNA synthesis is avoided. Specific interactions of the Rep proteins covalently linked to the 5Ј end of the genome with the preencapsidation complex could selectively sequester these molecules for DNA packaging. A question of future interest will concern the mechanism by which the virus avoids the initiation of packaging of multiple genomes and whether this is regulated by the number of Rep molecules anchored to the capsid surface. The results and the model presented here provide a basis for the analysis of these questions and a better understanding of the parvovirus DNA packaging process. 
